<DOC>
	<DOCNO>NCT01915264</DOCNO>
	<brief_summary>The study design non interventional collect data safety especially , severe hypoglycemia document symptomatic hypoglycemic episode effectiveness acarbose/metformin fixed-dose combination real-life treatment condition large sample type-2 diabetes patient India . The study objective evaluate severe hypoglycemia document symptomatic asymptomatic hypoglycemic event report adverse event . The study begin study approval ethic committee . All patient type 2 diabetes acarbose metformin monotherapy prescribe Glucobay M include study take informed consent . Patients observe 24 week ( 2 week ) .The study involve general examination patient , collection data like history disease , concomitant medication , drug dose etc . The study plan enroll 10000 subject multiple study center spread across India . The study data analyze appropriate statistical method .</brief_summary>
	<brief_title>GLucobay M - Evaluation Of Safety Effectiveness Type 2 Diabetes Not Well Controlled Monotherapy Real Life Practice</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Acarbose</mesh_term>
	<criteria>Patient enrol decision administer acarbose/metformin fix dose combination type2 diabetes management make attend physician basis best clinical practice patient need . Willing give inform consent participate study Patients receive antidiabetic medication acarbose , metformin monotherapy time enrollment study exclude . However , observation period , additional antidiabetic medication administer attend physician allow &amp; record case record form . Patient receive acarbose/metformin fix dose combination 3months prior enrollment . Exclusion criterion read conjunction local product information</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Acarbose ( 25/50mg ) Metformin ( 500mg ) fix dose combination</keyword>
</DOC>